Plasma cathepsin L: a prognostic marker for pancreatic cancer - Wikidata - awgldk - TriplyDB

Plasma cathepsin L: a prognostic marker for pancreatic cancer

Plasma cathepsin L: a prognostic marker for pancreatic cancer

http://www.wikidata.org/entity/Q34696906

about

Cathepsins in digestive cancers.

P2860

Q39237735-F33F6C1B-B54F-4A20-A1A5-60200908AA9F

P2860

Plasma cathepsin L: a prognostic marker for pancreatic cancer

http://www.wikidata.org/entity/Q34696906

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@ast

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@en

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@nl

type

label

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@ast

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@en

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@nl

prefLabel

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@ast

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@en

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@nl

P1433

Q34696906-B04B2479-7026-4201-A021-174A3F847491

P1476

Q34696906-119EEEB1-CB69-4C3E-BC11-C6FDF98FA918

P2093

Q34696906-0BC661AA-108C-400B-A512-870350187A4C

Q34696906-1AB9EA60-687C-4ECD-8367-85FCD192492B

Q34696906-21E954F7-E285-4D59-939C-930FE6199FA6

Q34696906-5FFD4D46-C819-4F90-BE9C-ACBD61BA3F9D

Q34696906-8B239839-11D0-453E-AE92-6A1200DEE887

Q34696906-8DADE24C-68B8-4E8F-80E2-44A06527B690

Q34696906-8DB60999-76AA-40E3-9263-07A3EC68FB65

Q34696906-C1D75002-88B4-4EC8-9973-2EB9078E3962

Q34696906-EEAE09C8-68A5-4D2E-AFA3-FF31A8215650

P2860

Q34696906-055A2130-6FF6-4041-AB1D-D10BCE74DE74

Q34696906-0A6238A1-C39A-49F2-ACD5-173C6D92397B

Q34696906-1C4049F2-1CD0-45D9-B7C2-4005F492B74F

Q34696906-361D4B1A-A7E2-4525-ADCF-C9AC50069A96

Q34696906-3AAB7CF5-0BA3-482A-93E6-1BF8EEABCD09

Q34696906-49E61F3F-07BF-4037-BB64-FA336BC6516F

Q34696906-62F5D41B-E4E4-4E9F-A18B-7C9A2D160847

Q34696906-71DB194B-4698-46D7-819C-0569CCDE2663

Q34696906-7D59EEDA-0E89-469C-A487-564DF6000C11

Q34696906-7E317622-8753-48F6-9055-77CC3BDAB2B8

P304

Q34696906-16CD7E9C-BD20-4946-BA95-395E08FD0B7F

P31

Q34696906-8C30EADF-E44A-4C7B-B7F3-064D695B33BA

P356

Q34696906-E1D0695A-E003-44BC-A9EA-216C905750CF

P407

Q34696906-1D050106-2CDC-4B78-AC06-9EFEC49F9EAC

P433

Q34696906-36348BA6-E83C-4D4A-8752-7CF21FEC8D65

P478

Q34696906-B5EFFE0B-965F-4036-9CFE-0D81D776743A

P50

Q34696906-86F6631F-FA69-455A-B3E5-8EBB6E3FE7FA

P577

Q34696906-57750E32-7A57-4499-87BC-5E2BA744FCB4

P5875

Q34696906-F9166505-01F4-4500-8DD5-40DF20E2D3B3

P698

Q34696906-3719BE6C-3439-40DA-A7E9-922D7859FA64

P932

Q34696906-CA622F7C-BF40-425C-9273-963F6C271A29

P356

WJG.V20.I46.17532

P1433

World Journal of Gastroenterology

P1476

Plasma cathepsin L: a prognostic marker for pancreatic cancer

@en

P2093

Anoop Saraya

http://www.w3.org/2001/XMLSchema#string

Nidhi Singh

http://www.w3.org/2001/XMLSchema#string

Prasenjit Das

http://www.w3.org/2001/XMLSchema#string

Ravindra Mohan Pandey

http://www.w3.org/2001/XMLSchema#string

Shyam S Chauhan

http://www.w3.org/2001/XMLSchema#string

Siddhartha Datta Gupta

http://www.w3.org/2001/XMLSchema#string

Siddhartha Srivasatava

http://www.w3.org/2001/XMLSchema#string

Surabhi Gupta

http://www.w3.org/2001/XMLSchema#string

Vikas Sachdev

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Cathepsin B and cystatins: evidence for a role in cancer progression

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association.

Evaluation of survival data and two new rank order statistics arising in its consideration.

Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells.

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L.

Surgery for pancreatic cancer: recent controversies and current practice.

P304

17532-17540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I46.17532

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269772843

http://www.w3.org/2001/XMLSchema#string

P698

25516668

http://www.w3.org/2001/XMLSchema#string

P932

4265615

http://www.w3.org/2001/XMLSchema#string